The presence or absence of B cells significantly alters the immune landscape in GBM: their absence correlates with increased M2 macrophages, while their presence is associated with a reduction in CD8+ T cells, weakening anti-tumor immunity. The gene discussed is CD8A; the disease is glioblastoma.